Mangoceuticals (MGRX) Cash from Operations (2023 - 2026)

Mangoceuticals has disclosed Cash from Operations across 4 years of filings, most recently posting 1311343.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 1311343.0, up 42.35% year-over-year; the trailing twelve-month figure through Mar 2026 was 4886817.0 (up 20.51% YoY), and the FY2025 annual result was 5850255.0, down 20.28% from the prior year.
• Cash from Operations came in at 1311343.0 for Q1 2026 at Mangoceuticals, down from 1077761.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 991131.0 in Q1 2024 to a low of 2274781.0 in Q1 2025.
• The 4-year median for Cash from Operations is 1311343.0 (2026), against an average of 1463288.38.
• Across the five-year window, Cash from Operations jumped 45.19% in 2024 and sank 129.51% in 2025, its largest moves.
• Mangoceuticals' Cash from Operations stood at 1697741.0 in 2023, then surged by 33.47% to 1129575.0 in 2024, then increased by 4.59% to 1077761.0 in 2025, then retreated by 21.67% to 1311343.0 in 2026.
• The last three Cash from Operations figures came in at 1311343.0 (Q1 2026), 1077761.0 (Q4 2025), and 1241264.0 (Q3 2025), per Business Quant data.